Keith A. Hall, Ph.D. has over 25 years of experience in the materials science and pharmaceutical and medical device biotech industries. Prior to OncoNano, Dr. Hall has held senior leadership positions at a variety of start-up companies including S.E.A. Medical Systems, Senzex Corporation, and Symyx Technologies overseeing and managing research and development efforts and developing corporate strategy including intellectual property and business development. He is also the founder of Hall and Associates Chemistry Consulting Solutions, LLC, a Silicon Valley based scientific consulting firm that has serviced a diverse clientele in the pharmaceutical and medical device space.
Dr. Hall received a B.S. in Chemistry from Harvey Mudd College, was a David M. Ritter Graduate Student Fellow at the University of Washington where he earned his Ph.D. in inorganic chemistry and was a Postdoctoral Research Fellow at Los Alamos National Laboratory where he studied radiopharmaceutical chemistry. He has over 25 peer reviewed publications and conference presentations and has over 50 allowed and pending patents spanning the development of novel inorganic, organic and polymeric materials, and pharmaceutical and medical device technologies.